After Hours
$
32.37
Change
-0.03 -0.09%
Volume
Volume 978,840
Sep 26, 2023, 7:59 p.m.
Quotes are delayed by 20 min
Previous close
$ 32.98
$ 32.40
Change
-0.58 -1.76%
Day low
Day high
$32.36
$32.96

52 week low
52 week high
$32.36
$54.93

Market cap
$186.20B
Average volume
24.69M
P/E ratio
8.63
Rev. per Employee
$939,084
EPS
3.75
Dividend
0.41
Div yield
5.06%
Ex dividend date
7/27/23
MarketWatch News on PFE
-
Free Covid Tests Are Coming. Here's How to Get Yours.
- Janet H. Cho
-
Pfizer maternal RSV vaccine recommended by CDC
- Eleanor Laise
-
Pfizer maternal RSV vaccine recommended by CDC advisors
- Eleanor Laise
-
The Covid Booster Rollout Is a Mess. That's Good News for Pfizer and Moderna.
- Josh Nathan-Kazis
-
New Cancer Drugs Are Changing the Odds of Survival
- Neal Templin
-
'This Is Not a Covid Vaccine Company,' Moderna CEO Says
- Josh Nathan-Kazis
-
Moderna aims to prove it’s ‘more than a COVID company’
- Eleanor Laise
-
Pfizer and Moderna Covid Vaccines Approved by FDA
- Josh Nathan-Kazis
- Loading more headlines...
Analyst Ratings
-
Johnson & Johnson: Analyst Recommendations and Target Price
- MarketRealist.com
-
Analyst Recommendations for Teva Pharmaceutical in July
- MarketRealist.com
-
Analysts’ Latest Recommendations on Mylan
- MarketRealist.com
Other News on PFE
-
The Big Pharma Trade: Ozempic Is In, Covid-19 Is Out
- Charley Grant
-
Covid Boosters Aren’t Reaching People Who Want Them
- Brianna Abbott
-
The Hedge Fund That Made a Killing Betting Against Lina Khan
- Caitlin McCabe
-
The Score: Moderna, Splunk, Fox and More Stocks That Defined the Week
- Francesca Fontana
-
AstraZeneca, Pfizer Agree Rare-Disease Deal
- Christian Moess Laursen
-
A Game Plan for Timing Your Flu, Covid and RSV Shots This Fall
- Sumathi Reddy
-
Stocks Tick Up in Quiet Session Ahead of Fed Decision
- Sam Goldfarb
-
He’s Been Naming Covid Variants. Not Everyone’s Happy.
- Brianna Abbott
-
CDC Endorses Covid-19 Boosters for Everyone Aged 6 Months and Older
- Brianna Abbott
-
FDA Approves Newest Covid-19 Boosters
- Liz Essley Whyte
-
Biden FTC’s Antitrust Bark Proves Worse Than Its Bite
- David Wainer
-
Biden Waves Through Another Covid Booster
- Marty Makary
-
Investors Say No Thanks to Gen-Z, Metaverse Funds
- Jack Pitcher
-
Expensive Drugs Targeted for First U.S. Price Negotiations
- Jared S. Hopkins
-
Germany Is Losing Its Mojo. Finding It Again Won’t Be Easy.
- Bojan Pancevski
- Loading more headlines...
Press Releases on PFE
-
Pfizer Prices $31,000,000,000 Debt Offering
- BusinessWire - BZX
-
Pfizer Announces Proposed Notes Offering
- BusinessWire - BZX
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com